BBIO
Bridgebio Pharma Inc
$31.6
Earnings Summary
Revenue | $4.09Mn |
Net Profits | $-177Mn |
Net Profit Margins | -4326.55% |
Highlights
Bridgebio Pharma Inc’s revenue jumped 1110.36% since last year same period to $4.09Mn in the Q3 2023. On a quarterly growth basis, Bridgebio Pharma Inc has generated 149.3% jump in its revenue since last 3-months.
Bridgebio Pharma Inc’s net profit fell -19.26% since last year same period to $-177Mn in the Q3 2023. On a quarterly growth basis, Bridgebio Pharma Inc has generated -12.1% fall in its net profits since last 3-months.
Bridgebio Pharma Inc’s net profit margin jumped 90.15% since last year same period to -4326.55% in the Q3 2023. On a quarterly growth basis, Bridgebio Pharma Inc has generated 55.04% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Bridgebio Pharma Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.92 |
EPS Estimate Current Year | -0.92 |
Highlights
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.92 - a -12.2% fall from last quarter’s estimates.
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.92.
Key Ratios
Key ratios of the Bridgebio Pharma Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -1.08 |
Highlights
Bridgebio Pharma Inc’s earning per share (EPS) fell -16.13% since last year same period to -1.08 in the Q3 2023. This indicates that the Bridgebio Pharma Inc has generated -16.13% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-02 | -0.82 | -1.08 | -31.71% |
2023-05-04 | -0.83 | -0.92 | -10.84% |
2023-08-03 | -0.83 | -0.98 | -18.07% |
₹0 US Stocks a/c Opening Fee